The Recall Desk
ModerateFDA (Devices)·Z-0599-2023·Announced 2022-12-21

DeRoyal BASIC NEURO PACK Medical Device Recall with Unspecified Reason

DeRoyal Industries is recalling 288 BASIC NEURO PACK medical device kits distributed across 23 U.S. states. The reason for the recall is not specified in available documentation.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II voluntary recall with no reported hospitalizations, injuries, or illnesses. The manufacturer initiated this precautionary recall, and the specific hazard is not documented in available sources, limiting severity assessment.

Plain-English summary

DeRoyal Industries Inc is recalling its BASIC NEURO PACK (Reference 89-7523.15), a medical device kit. A total of 288 kits are affected, distributed across 23 U.S. states including Tennessee, Texas, New York, Wisconsin, Florida, Virginia, Massachusetts, Arizona, Missouri, Connecticut, New Jersey, Pennsylvania, North Carolina, Louisiana, Michigan, Minnesota, Ohio, Indiana, Kansas, Illinois, Alabama, Georgia, and Mississippi.

The FDA classified this as a Class II recall initiated voluntarily by the manufacturer on November 3, 2022. However, the specific reason for the recall is not documented in the available FDA sources.

The affected product lots are: Lot 56611821 (expiration August 1, 2026) and Lot 56881417 (expiration September 1, 2026). The recall status is ongoing as of the most recent update.

The recalled product

Product
DeRoyal BASIC NEURO PACK, REF 89-7523.15
Manufacturer
DeRoyal Industries Inc

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot Numbers: Lot 56611821 exp 8/1/2026
  • Lot 56881417 exp 9/1/2026

Distribution

Distribution scope not specified by the agency.